Evidence map›Paper›PMID 41978771›Full record

ArticleFrontiers in genetics2026

Pharmacist workforce training in pharmacogenomics with a focus on rural and underserved areas.

Moataz Mohamed, Pamala A Jacobson, Alyssa Johnson, Jacob Tyler Brown

Abstract read
In one paragraph

Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moataz MohamedExperimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
Pamala A JacobsonExperimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
Alyssa JohnsonExperimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
Jacob Tyler BrownPharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Our primary objective is to demonstrate the benefits of pharmacogenomic (PGx) education for pharmacists that serve rural and underserved communities through pre- and post-surveys assessing their overall change in knowledge and attitudes towards PGx testing. Methods: Participants completed a 16-week, asynchronous didactic course, attended in-person case-based PGx presentations from content experts, and viewed materials from a two-day international PGx conference. Pre- and post-surveys designed to measure changes in self-assessed knowledge, confidence, and attitudes towards PGx testing were completed by all participants. All participants who had completed the program were also invited to take a longitudinal survey to assess long-term program impacts. Results: Twenty-three participants located throughout the state of Minnesota completed the program. Participant's confidence in their PGx knowledge increased significantly from the beginning of the program to the end. In the longitudinal survey, nearly all participants (93%) responded "yes" when asked if the program influenced their perspectives on the importance of PGx in pharmacy and healthcare, and nearly 75% responded "yes" when asked if the PGx certificate program had contributed to their professional growth or career advancement. The majority (87%) reported that they had shared the knowledge gained from the program with other healthcare providers. Conclusion: These findings show a high level of impact on PGx knowledge in pharmacists practicing in rural and underserved areas, and highlight increased likelihood of PGx implementation after the education program.

Indexed as

educationpharmacogeneticspharmacogenomicsruralunderserved

Identifiers

PMID41978771
PMCPMC13070540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.